Post by 4DMedical

A major milestone for 4DMedical: CT:VQ™ has received CE Mark certification, enabling commercial launch across the European Union. This is an important step in bringing our non-contrast ventilation-perfusion imaging technology to hospitals and clinicians across Europe, alongside existing FDA clearance in the U.S. CT:VQ™ is designed to provide quantitative functional lung insights from routine non-contrast CT scans, without the need for radiotracers or specialised nuclear medicine infrastructure — helping radiology and pulmonary teams access ventilation and perfusion information within familiar CT workflows. We’re looking forward to working with hospitals, radiologists and respiratory physicians across the region on clinical adoption, evaluation and research. In a separate announcement today, 4DMedical also secured AU$83 million in private placement funding to support growth initiatives, including European expansion. See press release link in Comments. #MedTech #Radiology #Pulmonology #MedicalDevices #ImagingInnovation #HealthcareTechnology #Europe #4DMedical